Amgen (AMGN) EBITDA Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Amgen (AMGN) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.13 Bn | 193.14 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.53 Bn | 176.35 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.46 Bn | 123.61 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.89 Bn | 73.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.12 Bn | 55.94 Bn | 1.37 Bn |
| 6 | Moderna | 53.31 Bn | 48.17 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.36 Bn | 30.05 Bn | 992.69 Mn |
| 8 | Biogen | 31.72 Bn | 30.43 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.32 Bn | 29.32 Bn | 1.16 Mn |
| 10 | Insmed | 27.78 Bn | 26.62 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 402.00 |
| Mar 31, 2026 | 337.00 |
| Dec 31, 2025 | 114.00 |
| Sep 30, 2025 | -250.00 |
| Jun 30, 2025 | 1,448.00 |
| Mar 31, 2025 | -1,098.00 |
| Dec 31, 2024 | 136.00 |
| Sep 30, 2024 | 132.00 |
| Jun 30, 2024 | 945.00 |
| Mar 31, 2024 | -220.00 |
| Dec 31, 2023 | -1,377.00 |
| Sep 30, 2023 | -914.00 |
| Jun 30, 2023 | 695.00 |
| Mar 31, 2023 | -45,437.00 |
| Dec 31, 2022 | 44,585.00 |
| Sep 30, 2022 | 699.00 |
| Jun 30, 2022 | -708.00 |
| Mar 31, 2022 | 642.00 |
| Dec 31, 2021 | -181.00 |
| Sep 30, 2021 | 2,277.00 |